logo

Regeneron Pharmaceuticals (REGN)



Trade REGN now with
  Date
  Headline
5/17/2022 7:05:46 AM Vyriad Raises $29.5 Mln In Series B Funding Led By Renowned Genetics Entrepreneur
5/16/2022 8:04:10 AM Elicio Therapeutics Announces Clinical Supply Deal With Regeneron To Evaluate ELI-002 With Libtayo In KRAS-Driven Tumors
5/4/2022 6:33:10 AM Regeneron Q1 GAAP EPS $8.61; Non-GAAP EPS $11.49
4/19/2022 7:06:32 AM Regeneron To Acquire Checkmate Pharma For $10.50/Shr
4/19/2022 6:42:24 AM SpringWorks Therapeutics Announces Deal With Regeneron To Evaluate Nirogacestat With REGN5458
4/14/2022 7:02:57 AM Regeneron Says FDA Extends Review Of BLA For REGEN-COV For Treatment And Prophylaxis Of COVID-19
4/7/2022 1:01:23 AM Regeneron Pharma And Sanofi: EC Expands Marketing Authorization For Dupixent In The European Union
4/4/2022 1:03:00 AM Regeneron Pharma: FDA Accepts Dupixent For Priority Review In Patients With Eosinophilic Esophagitis